Publication: Role of microRNA in severe asthma
Issued Date
2019-01-01
Resource Type
ISSN
22125353
22125345
22125345
Other identifier(s)
2-s2.0-85056572696
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Respiratory Investigation. Vol.57, No.1 (2019), 9-19
Suggested Citation
Kittipong Maneechotesuwan Role of microRNA in severe asthma. Respiratory Investigation. Vol.57, No.1 (2019), 9-19. doi:10.1016/j.resinv.2018.10.005 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/52152
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Role of microRNA in severe asthma
Author(s)
Other Contributor(s)
Abstract
© 2018 The Japanese Respiratory Society The various roles of microRNAs (miRNAs) in the epigenetic regulation of human disease are gaining importance as areas of research, and a better understanding of these roles may identify targets for development of novel therapies for severe asthma. MiRNAs, a class of small non-coding RNAs that serve as post-transcriptional gene repressors, are recognized as critical components in regulating tissue homeostasis. Alteration in miRNA expression disrupts homeostasis and is an underlying mechanism for development of chronic respiratory diseases, including asthma. Differential profiles of miRNA expression are involved in inflammation and remodeling pathogenicity via activating airway structural cells and immune cells and inducing cytokine releases. miRNA action leads to asthma progression from mild to severe stages. Here, current knowledge of the heterogeneous roles of miRNAs in severe asthma, including biological mechanisms underlying Th2 and macrophage polarization, type 2 innate lymphoid cell (ILC2) biology regulation, steroid-resistant asthma phenotype, airway smooth muscle (ASM) dysfunction, and impaired anti-viral innate immune, are reviewed.